INTRODUCTION An early trial of a new drug called mavrilimumab suggests that it may become a useful new treatment for people with moderate to severe rheumatoid arthritis. WHAT DO WE KNOW ALREADY? Despite big steps forward in the treatment of rheumatoid arthritis in recent years, there are still many people who don’t benefit much from the available […]